2-(bis(2-hydroxyethyl)amino)-1,4-benzoquinone has been researched along with Leukemia in 1 studies
*Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Begleiter, A; Giorgianni, A; Guziec, F; Guziec, LJ; Hasinoff, BB; Jiang, Y; Wu, X; Yalowich, JC; Yang, S | 1 |
1 other study(ies) available for 2-(bis(2-hydroxyethyl)amino)-1,4-benzoquinone and Leukemia
| Article | Year |
|---|---|
Structure-activity study of the interaction of bioreductive benzoquinone alkylating agents with DNA topoisomerase II.
Topics: Alkylating Agents; Animals; Benzoquinones; Cell Proliferation; CHO Cells; Cricetinae; DNA Adducts; DNA Damage; DNA Topoisomerases, Type II; Drug Interactions; Electrophoresis, Agar Gel; Leukemia; Oxidative Stress; Quantitative Structure-Activity Relationship; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2006 |